Zealand Pharma AS (OCSE:ZEAL)
kr 730 0 (0%) Market Cap: 51.57 Bil Enterprise Value: 43.49 Bil PE Ratio: 0 PB Ratio: 5.83 GF Score: 67/100

Q1 2023 Zealand Pharma A/S Earnings Call Transcript

May 11, 2023 / 12:00PM GMT
Release Date Price: kr245.6 (+11.64%)
Operator

Hello, and welcome to the Zealand Pharma Conference Call. I would like to advise all participants that this call is being recorded. Thank you. I'd now like to welcome Anna Krassowska to begin the conference. Anna, over to you.

Anna Krassowska;S;VP of IR;Corporate Communications;Adam Sinding Steensberg;S;
Zealand Pharma A;Zealand Pharma A

/-&

Welcome, and thank you for joining us today to discuss Zealand's interim results for the first quarter of 2023. With me today are the following members of Zealand's management team, Adam Steensberg, President and Chief Executive Officer; Henriette Wennicke, Chief Financial Officer; and David Kendall, Chief Medical Officer. You can find the related company announcement and interim report on our website at zealandpharma.com. As described on Slide 2, we will be making forward-looking statements that are subject to risks and uncertainties. With that, I will turn the call over to Adam Sabre, President and CEO. Adam?

- /

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot